The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of EGFR tyrosine kinase inhibitors in the management of brain metastases from EGFR-mutated and wild-type (WT) non-small cell lung cancer (NSCLC): A survival analysis.
Antonio Picone
No relevant relationships to disclose
Tindara Franchina
No relevant relationships to disclose
Alessandro Russo
No relevant relationships to disclose
Claudia Proto
No relevant relationships to disclose
Fabio Raiti
No relevant relationships to disclose
Carmelo Buda
No relevant relationships to disclose
Giuseppe Chiofalo
No relevant relationships to disclose
Giuseppa Ferraro
No relevant relationships to disclose
Maria Picciotto
No relevant relationships to disclose
Antonino Scimone
No relevant relationships to disclose
Giuseppe Toscano
No relevant relationships to disclose
Mariangela Zanghì
No relevant relationships to disclose
Vincenzo Adamo
No relevant relationships to disclose